Minondas, Stieven Jhon R.
HRN: 10-05-77 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/06/2023
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
03/06/2023
03/12/2023
IV
165mg
Q12
Typhoid
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes